Introduction {#sec0005}
============

Group B streptococcus (GBS) is a commonly recognized cause of sepsis and meningitis in neonatal and young infants. Invasive GBS infection is classified into early onset GBS disease (EOD, day 0--6), late onset GBS disease (LOD, day 7--89) and ultra late onset GBS disease (ULOD, after 3 months of age) [@bib0005], [@bib0010]. The characteristics of EOD and LOD have been well documented, but little is known about ULOD. Several cases of ULOD have been reported [@bib0010], but ULOD after 1 year of age is rare and recurrent case is especially rare. We report the first case of recurrent invasive ultra late onset GBS infection.

Case report {#sec0010}
===========

The patient was the first female child of healthy unrelated parents. She was diagnosed with hydrops fetalis and drainage of pleural effusions was performed before birth. At 30 weeks and 5 days gestation, the patient was born via caesarian section because of an increase in pleural effusion. Her birth weight was 2325 g, but the estimated body weight was considered to be about 1200 g because of edema. The patient was intubated and general care was provided in the NICU department. She was diagnosed with thoracic congenital lymphatic dysplasia using scintigraphy. She was treated using octeotides, diuretics and dexamethasone for two months and was eventually discharged at one year of age with home oxygen therapy. Maternal GBS colonization was negative. During NICU admission, GBS strains were never isolated from any cultures. There was no history of bacteremia nor seizures. She had no other significant past medical history except for a moderate delay of developmental milestones including walking at 2 years and 2 months of age, and still unable to speak meaningful words at 3 years of age.

At 2 years 8 months of age, the patient was admitted to a hospital with a history of high-grade fever (39.3 °C) and seizures. Laboratory studies revealed a total WBC count of 22600/mm^3^ with 76% neutrophils and 19% lymphocytes, and a C-reactive protein (CRP) result of 0.05 mg/dL. She was treated with intravenous sulbactam/ampicillin with the diagnosis of suspected bacteremia. Within 24 h her fever began to decrease and her mental status improved. Twelve hours after admission, blood culture was growing GBS. CRP increased to 7.33 mg/dL in 12 h. Nasal culture did not reveal GBS. She was discharged after 10 days of intravenous antimicrobial therapy.

Five months after the first episode of GBS infection, at 3 years 1 month of age, she was admitted to a hospital for fever up to 40 °C. About two hours after admission, she had seizures. The convulsions were generalized tonic-clonic seizures, which were controlled with repeated doses of intravenous diazepam and midazolam along with supportive measures. Laboratory studies revealed a serum total WBC count of 9400/mm^3^ with 77% neutrophils and 17% lymphocytes, CRP 0.14 mg/dL and normal CSF parameters. The patient was empirically started on intravenous ampicillin and ceftriaxone. On the second day after admission, she was still febrile (40 °C) and toxic, with tachycardia including a heart rate of 180/min. Her neurological status did not improve. Laboratory studies revealed a serum total WBC count of 14200/mm^3^, AST 545 IU/L, ALT 241 IU/L, CRP 17.76 mg/dL and procalcitonin \>100 μg/L. The electroencephalogram showed diffuse slow waves.

The patient was transferred to a tertiary hospital with a diagnosis of sepsis and encephalopathy. Antimicrobials were continued. Ultrasound revealed no signs of endocarditis. Neither intubation nor therapeutic hypothermia was performed. GBS was isolated in the blood culture, but CSF and urine cultures were sterile, and nasal and rectal cultures did not reveal GBS. MRI of the head revealed clinically mild encephalopathy with a reversible splenial lesion; MERS. After isolation of GBS from the blood, antimicrobials were deescalated to ampicillin alone for 14 days. The GBS isolate was serotyped as GBS type V. The patient was discharged on the 40th hospital day with mild neurologic sequelae, including brain atrophy. She also showed signs of temporal regression of motor function, which improved over time.

Quantitative immunoglobulin (Ig) and complement (C) values were normal (IgG 763 mg/dL, IgA 51 mg/dL, IgM 161 mg/dL, C3 71.0 mg/dL, C4 17.0 mg/dL, CH50 15.9 IU/mL). Neutrophil oxidative burst test results were normal (97%). IgG subclasses were also normal (IgG~1~ 785.0 (65.9%), IgG~2~ 324.0 (27.2%), IgG~3~ 17.2 (1.44%), IgG~4~ 65.0 (5.46%)). Neutrophil count was normal since birth, and no family members were compromised hosts. HIV testing was negative.

Discussion {#sec0015}
==========

We made two important clinical observations in this case. First, recurrent ULOD GBS infection is extremely rare among children over 1 year of age. To our knowledge, this is the first report of recurrent invasive GBS infection in ULOD. Second, ULOD GBS infection over 1 year of age, compared to infection before 1 year of age can be associated with underlying conditions.

A 2008 report from the USA identified 90 cases of invasive GBS disease in children aged 1 through 14 years from 1999 to 2005, but the details of clinical data for each case have not been reported [@bib0015]. The ULOD incidence rate in Japan was unknown, but the estimated incidence of invasive GBS disease in the United States is 0.22 per 100,000 population in individuals aged 1 through 14 years [@bib0015]. Ten other cases of ULOD among children aged 1 through 14 years have been reported [@bib0020], [@bib0025], [@bib0030], [@bib0035]. Demographics and clinical data for each case are summarized in [Table 1](#tbl0005){ref-type="table"}. Three patients were male, 6 were female (including our patient), and for 3, the gender was not reported. Only our case had recurrent ULOD infection. In our patient, both infections presented as sepsis: the first infection as sepsis and the second infection as sepsis with encephalopathy [@bib0040]. Although relapse or recurrence of neonatal and infantile GBS infection has been described, recurrent invasive GBS infection in ULOD has not been reported. Hypotheses regarding the cause of recurrence in EOD and LOD have been suggested by many authors. The combined effect of immature immune mechanisms and persistent mucosal colonization may permit reinvasion from the mucosal surface and the establishment of recurrent systemic GBS infection [@bib0045], [@bib0050]. In our patient, GBS serotype V was found in the second infection but we did not examine the serotype in the initial infection. Recurrent GBS infection does not necessarily imply relapse with the same GBS serotype.

The definition of ULOD is somewhat ambiguous. ULOD is typically defined with a lower age threshold (\>90 days), but its upper age limit is either variably defined or undefined. We chose to apply the term to children aged over 90 days to 14 years as Phares et al. defined [@bib0015]. The term "ULOD" is an extension of the terms of "EOD" and "LOD" neonatal GBS. Although the term "ULOD" may be reasonable to refer to sepsis that occurs in infants, it may be inappropriate to apply to sepsis in older children and ULOD above 1 year of age may have different pathophysiology. Therefore we believe that ULOD above 1 year of age should be conceptualized separately as "childhood" or "pediatric" ULOD.

ULOD GBS infection over 1 year of age, compared to infection before 1 year of age, appears to be associated with underlying conditions. In our review, 66% (8/12) had at least 1 underlying condition including neurologic disorders, hydrops fetalis with lymphatic dysplasia, congenital ectodermal dysplasia with hyper IgM globulinemia and congenital heart disease ([Table 1](#tbl0005){ref-type="table"}). Three patients had undergone surgery for cerebrospinal fluid drainage, ventriculo-peritoneal shunt and ventriculostomy. A previous study showed that only 11% of children aged 90 days through 12 months had an underlying condition (excluding preterm birth), but 44% of children aged 1 through 14 years had at least 1 underlying condition, including neurologic disorders, immunosuppressive conditions, asthma, malignancy and renal disease [@bib0015]. Our review also suggests that ULOD above 1 year of age is more likely to be associated with underlying conditions. Our patient was born preterm and had hydrops fetalis and lymphatic dysplasia. Lymphatic dysplasia may be associated with insufficient immunity. In a previous report, the authors emphasized the importance of preterm birth for ULOD GBS meningitis, where ULOD referred to infants less than 1 year old [@bib0010]. Our findings including children aged 1 through 14 years did not suggest prematurity as a risk for ULOD.

Recurrent ULOD GBS infection is extremely rare among children over 1 year of age. ULOD over 1 year of age is more likely to be associated with underlying conditions compared to younger children. In patients with underlying conditions, ULOD may occur even over 1 year of age and can recur, therefore careful clinical evaluation is necessary.
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Characteristics of invasive GBS disease among children aged 1 through 14 years.

Table 1

  Patient   Reference number   Age (y,m)   Gender   Gestational age   Clinical Manifestation                             Underlying Condition                                      Outcome   Serotype
  --------- ------------------ ----------- -------- ----------------- -------------------------------------------------- --------------------------------------------------------- --------- ----------
  1         [@bib0020]         1y4m        Male     Term              Bacteremia                                         None                                                      Alive     NT
  2         [@bib0020]         1y6m        NR       Term              Bacteremia                                         None                                                      Alive     II
  3         [@bib0020]         1y9m        Female   Term              Endocarditis                                       Congenital heart disease                                  Alive     Ia
  4         [@bib0020]         3y          Male     Term              Bacteremia                                         None                                                      Alive     III
  5         [@bib0020]         12y         Female   NR                Ventriculostomy-associated infection, meningitis   AV malformation, intraventricular hemorrhage              Death     Ib/c
  6         [@bib0020].        14y         Female   NR                VP shunt infection, meningitis                     Arnold-Chiari malformation                                Alive     NT
  7         [@bib0025]         1y5m        NR       34w3d             Bacteremia                                         Cerebellar tumor                                          Alive     NT
  8         [@bib0025]         3y8m        NR       37w2d             Bacteremia                                         Congenital ectodermal dysplasia, hyper-IgM globulinemia   Alive     NT
  9         [@bib0030]         5y          Male     NR                Meningitis                                         None                                                      Alive     NT
  10        [@bib0035]         9y          Female   NR                Meningitis                                         Lumbar spina bifida, hydrocephalus with VP shunt          Alive     NT
  11        Our patient        2y8m        Female   30w5d             Sepsis                                             Hydrops fetalis, lymphatic dysplasia                      Alive     NT
  12        Our patient        3y1m        Female   30w5d             Sepsis, encephalopathy                             Hydrops fetalis, lymphatic dysplasia                      Alive     V

NT, not tested; NR, not reported; VP, ventriculoperitoneal.
